ArticleIrish journal of medical science2025
Influence of Transcobalamin II (TCN2) and its receptor (CD320) gene polymorphisms on circulating TCN2 and CD320 levels in individuals with vitamin B12 deficiency.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundVitamin B12 deficiency is a health concern leading to neurological and hematological disorders with genetic factors. This study investigated the effects of polymorphisms in the Transcobalamin II (TCN2, rs1801198) gene and its receptor CD320 (rs2336573) on serum vitamin B12 levels, circulating TCN2 and CD320 levels, and basic hematological parameters.
methodsPatients with vitamin B12 deficiency and healthy controls were included in the study. Genotyping was performed using the TaqMan SNP method, and serum TCN2 and CD320 concentrations were measured by ELISA. Vitamin B12 and hematological parameters were measured via autoanalyzer.
resultsGenotype and allele frequencies of TCN2 and CD320 polymorphisms did not differ significantly between patients and controls. Among individuals with vitamin B12 deficiency, carriers of the TCN2 CG genotype showed higher mean corpuscular volume (MCV) and lower total iron-binding capacity (TIBC), whereas those with the CC genotype had reduced CD320 levels. Carriers of the CD320 CC genotype showed lower CD320 and TIBC levels compared with controls. In individuals with B12 deficiency and the TCN2 CC genotype, B12 levels were inversely related to MCV and positively correlated with TCN2 and CD320 levels. Likewise, in CD320 CC carriers, CD320 levels showed a positive correlation with both vitamin B12 and TCN2.
conclusionAlthough no direct genetic association with B12 deficiency was identified, observed reductions in TCN2 and CD320 levels, along with alterations in related biochemical parameters, suggest a potential role of these genes in B12 metabolism. More extensive studies are needed to confirm these findings.
Indexed as
Identifiers
41175296What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.